Background {#Sec1}
==========

The manipulation of recombinant DNA molecules is an indispensable step in modern high-throughput protein crystallization studies \[[@CR1]\]. Restriction enzyme/ligase cloning, which relies on restriction enzyme digestion and ligation, is a simple and easy way to move a fragment of double-stranded DNA from one plasmid to another \[[@CR2]\]. However, this technique has two limitations \[[@CR3]\]: it is ineffective when lack of unique restriction sites and sometimes results in introduction of unwanted extra sequences. To circumvent these limitations, various restriction endonuclease cleavage site--independent cloning methods have recently been developed \[[@CR4]--[@CR21]\]. These methods have made cloning more accessible in cases in which conventional restriction site cloning was difficult or impossible. While as alternative cloning strategies are still required for more choices.

The restriction-free (RF) cloning strategy, as described extensively in the literature, was developed as a powerful tool for reconstituting genes in circular vectors \[[@CR3], [@CR22]\]. Because RF cloning requires no alterations in the plasmid or the gene of interest, it is exceptionally well-suited for high-throughput cloning. The gene of interest is amplified in a regular polymerase chain reaction (PCR), which produces a primer pair that, once annealed to the vector of interest, is extended in a linear amplification reaction. Thus, this method relies on amplified genes functioning as primers. However, this approach also has limitations. First, the motion of large DNA fragments and the formation of secondary structures will affect the efficiency of PCR. Second, this method relies on digestion with *Dpn*I, which cleaves methylated DNA, to remove parental plasmids. The efficiency of *Dpn*I treatment is influenced by many factors, and requires vector propagation in Dam^+^ strains \[[@CR23]\].

In this paper, we describe a simple and fast method for performing gene reconstitution by modified restriction-free (MRF) cloning. In this method, two rounds of PCR generate two DNA fragments with compatible 5\' or 3' cohesive ends, which are therefore able to ligate to each other. This new method is independent of the existence of restrictions sites and *Dpn*I treatment. Using this method, we made 46 constructs with inserts of variable size, with average cloning efficiency higher than 85%. The efficiency was not significantly affected by the insert length up to 20 kb.

Results {#Sec2}
=======

Method overview and primer design {#Sec3}
---------------------------------

Figure [1](#Fig1){ref-type="fig"} shows the scheme for MRF cloning. We define the 5--8 bp DNA fragments before the insert site A as "5' overhang" and those after insert site B as "3' overhang" (see Fig. [1](#Fig1){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S1 and Additional file [2](#MOESM2){ref-type="media"}: Figure S2). To replace a gene (Fig. [1](#Fig1){ref-type="fig"}, red line) in a vector between sites A and B, we designed eight primers (Additional file [3](#MOESM3){ref-type="media"}: Table S1): primer 1, forward primer, which contains a \~25 bp sequence homologous to the positive strand of the gene; primer 2, reverse primer, which contains a \~25 bp sequence homologous to the negative strand of the gene; primer 3, forward primer, which is the same as primer 1 but has an additional 5' overhang at the 5' end; primer 4, reverse primer, which is the same as primer 2 but has an additional 3' overhang at the 5' end; primer 5, forward primer, which contains a \~25 bp sequence homologous to the negative strand of the vector; primer 6, reverse primer, which contains a \~25 bp sequence homologous to the positive strand of the vector; primer 7, reverse primer, which is the same as primer 5 but has an additional 5\' overhang at the 5' end; primer 8, reverse primer, which is the same as primer 6 but has an additional 3' overhang at the 5' end. All primers were designed with G or C as the 5' and 3' terminal nucleotide.Fig. 1Schematic representation of MRF cloning. The insert gene or vector was amplified by regular double-primer PCR using genomic DNA, cDNA, or the original vector as template. Compatible cohesive ends of insert gene or vector were created by two single-primer linear PCRs performed in parallel, followed by annealing of the two PCR products. Inserts and acceptors with compatible cohesive ends were then assembled by ligation

We used two pairs of primers, primer 1/primer 2 and primer 5/primer 6, to generate two DNA fragments, using the target gene and vector as templates, respectively. The resultant PCR products were gel purified. We then amplified these two DNA fragments in two separate PCR reactions containing either forward or reverse primer, which will add 5' overhang or 3' overhang to the PCR products (Fig. [1](#Fig1){ref-type="fig"}). Finally, DNA fragments with complementary overhang at the 5' or 3' end were able to anneal to each other, and were joined by DNA ligase (Fig. [1](#Fig1){ref-type="fig"}). The ligated products were then transformed into DH5α competent cells. The inserted genes were verified by colony PCR and further confirmed by DNA sequencing.

MRF cloning can assemble insert DNA fragment into target vector {#Sec4}
---------------------------------------------------------------

We first tested this protocol to reconstitute the *E. coli radA* gene into pET22b. Based on the initial success of the protocol, we continued to employ it to generate the constructs needed for our studies. For example, we planned to replace the *radA* gene in vector pET22b between the start codon ATG (289) and the sequence CACCACCACCACCACCAC (157) (Fig. [1](#Fig1){ref-type="fig"} and Additional file [1](#MOESM1){ref-type="media"}: Figure S1) to yield a new construct with the gene under the control of a T7 promoter and a C-terminal His~6~-tag to facilitate protein purification. As shown in Fig. [1](#Fig1){ref-type="fig"}, to replace the *radA* gene in the vector, two parallel PCRs were performed to amplify each DNA fragment using the primer pairs pet22b1/pet22b2 and radA1/radA2, as shown in Additional file [3](#MOESM3){ref-type="media"}: Table S1, using pET22b or *E. coli* genomic DNA as templates to generate DNA fragments "1" and "2". Amplified products were separated by 1% agarose gel electrophoresis and purified by gel extraction. We then performed two separate single-primer linear PCRs: (1) using pet22b3 or pet22b4 alone, with DNA fragment "1" as the template, to obtain single-strand DNA fragment "3-1" or "3-2"; and (2) using radA3 or radA4 alone, with DNA fragment "2" as template, to obtain single-strand DNA fragment "4-1" or "4-2". Fragments "3-1" and "3-2" and "4-1" and "4-2" were then annealed to obtain double-strand DNA fragments "3" and "4", which have sticky ends that can ligate with other compatible ends. For single-primer PCR, we used \~500 ng of template, about 10 times more than the standard amount recommended for double-primer PCR (Table [1](#Tab1){ref-type="table"}), as DNA amplification in single-primer PCR is linear (only 30-fold for 30 PCR cycles). As the efficiency of cohesive ligation is higher than that of blunt-end ligation, the parental DNA of the products of second-round PCR did not need to be removed. After PCR purification, these second-round PCR products were ready for ligation. In each transformation, we routinely checked eight colonies at random from each transformation by colony PCR with a forward primer annealing to vector and a reverse primer annealing to the inserted gene.Table 1PCR reaction componentsReaction 1Reaction 2aReaction 2bTemplate DNA\~50 ng\~500 ng\~500 ngForward primer (100 μM)0.25 μL0.25 μLReverse primer (100 μM)0.25 μL0.25 μLPhusion GC Buffer (5×)10 μL10 μL10 μLdNTPs (10 mM)1 μL1 μL1 μLDMSO (100%)1.5 μL1.5 μL1.5 μLPhusion High Fidelity DNA\
Polymerase1 μL1 μL1 μLAdd water to50 μL50 μL50 μL

The agarose gel in Fig. [2](#Fig2){ref-type="fig"} shows the DNA products of one sample at successive steps of our procedure. Plasmid alone, prior to PCR, shows two major bands (Fig. [2](#Fig2){ref-type="fig"}, lane 1). After the double-primer PCR with forward (F) and reverse (R) primers, major bands can be seen at the expected sizes corresponding to the PCR-synthesized linear DNA (Fig. [2](#Fig2){ref-type="fig"}, lanes 2 and 3). Single-primer PCR with forward (F) or reverse (R) yielded bands at the expected size of \~5.5 kb (Fig. [2](#Fig2){ref-type="fig"}, lane 5) and \~1.4 kb (Fig. [2](#Fig2){ref-type="fig"}, lane 6) after annealing the products of single-primer PCR, representing the PCR-synthesized linear DNA with cohesive ends. Additional smaller bands represent non-specific PCR products or single-strand DNA. The ligation of insert into plasmid vector is performed by T4 DNA ligase using a molar ratio of 1:3 vector to insert. As shown in Fig. [2](#Fig2){ref-type="fig"}, lane 8 (before ligation) and 9 (after ligation), insert and vector were ligated to one another and shifted to a higher molecular weight. The inserted genes were amplified by colony PCR. The presence of forward and reverse cloning sites were confirmed by DNA sequencing (Fig. [3a](#Fig3){ref-type="fig"}).Fig. 2Gel electrophoresis separation of double-primer and single-primer PCR products. 1: Parental plasmid pET22b alone; 2: PCR product from reaction with primers pet22b1/pet22b2 using plasmid pET22b as template; 3: PCR product from reaction with primers radA1/radA2 using *E. coli* genomic DNA as template; 4: PCR product from reaction with primers GeneCluster3-1/GeneCluster3-2 using *E. coli* genomic DNA as template; 5: annealed PCR products from two single-primer linear reactions using primer pet22b3 or pet22b4, and the DNA sample from lane 2 as template; 6: annealed PCR products from two single-primer linear reactions using the primer radA2fw or radA2rv, and the DNA sample from lane 3 as template; 7: annealed PCR products from two single-primer linear reactions using the primer GeneCluster3-3 or GeneCluster3-4, and the DNA sample from lane 4 as template; 8: mixture of DNA samples from lanes 5 and 6 in a molar ratio of 1:3, ready for ligation; 9: mixture of DNA samples from lanes 5 and 6 in a molar ratio of 1:3, after ligation; 10: mixture of DNA samples from lanes 5 and 7 in a molar ratio of 6:1, ready for ligation; 11: mixture of DNA samples from lanes 5 and 7 in a molar ratio of 6:1, after ligation; 12: DNA ladder. PCR products were purified using a QIAquick purification kit (Qiagen) and electrophoresed in 1% agarose with Tris-acetate (40 mM Tris, 20 mM sodium acetate, 1 mM EDTA, pH 8.0) as the running buffer Fig. 3DNA sequencing reveals that genes were correctly placed in the plasmid. **a** Upper panel: DNA sequencing results of the forward cloning site of pET22b-*radA*; lower panel: DNA sequencing results of the reverse cloning site of pET22b-*radA*. **b** Upper panel: DNA sequencing results of the forward cloning site of pET22b-gene cluster 3; lower panel: DNA sequencing results of the reverse cloning site of pET22b-gene cluster 3

Long DNA fragment cloning {#Sec5}
-------------------------

To test the suitability of our method for a large DNA fragment, we used it to insert a 20 kb DNA fragment from the *E. coli* genome (200485-220925, Gene Cluster 3, Table [2](#Tab2){ref-type="table"} and Additional file [4](#MOESM4){ref-type="media"}: Table S4) containing 21 genes into pET22b between the start codon ATG (289), and the sequence CACCACCACCACCACCAC (157) (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). Gene Cluster 3 was amplified using the primer pair GeneCluster3-1/GeneCluster3-2, as shown in Additional file [4](#MOESM4){ref-type="media"}: Table S4, using *E. coli* genomic DNA as template (Fig. [2](#Fig2){ref-type="fig"}, lane 4). Gene Cluster 3 with a sticky end was generated by single-primer PCR, as shown in Fig. [1](#Fig1){ref-type="fig"}, using primer GeneCluster3-3 or GeneCluster3-4 (Additional file [4](#MOESM4){ref-type="media"}: Table S4) (Fig. [2](#Fig2){ref-type="fig"}, lane 7). The ligation of Gene Cluster 3 DNA fragment into pET22b was performed with T4 DNA ligase using a molar ratio of vector to insert at 6:1. As shown in Fig. [2](#Fig2){ref-type="fig"}, lane 10 (before ligation) and 11 (after ligation), insert and vector were ligated to one another and shifted to a higher molecular weight. The inserted genes were amplified by colony PCR. The presence of forward and reverse cloning sites were confirmed by DNA sequencing (Fig. [3b](#Fig3){ref-type="fig"}).Table 2Genes cloned and efficiency of reconstitutionGeneGene IDLength (bp)VectorPositive^a^*yaiS*946967558pET22b8 (7)*ybaY*945070574pET22b8 (8)*nfnB*945778654pET22b8 (6)*yohK*949125696pET22b8 (8)*rlmB*948694732pET22b8 (8)*nhoA*947251846pET22b8 (7)*dapA*946952879pET22b8 (8)*deoC*948902780pET22b8 (6)*deoA*9489011,230pET22b8 (5)*deoB*9489101,224pET22b8 (8)*deoD*945654721pET22b8 (7)*yjjJ*9448831,332pET22b8 (8)*lplA*9448651,017pET22b8 (8)*ytjB*946089645pET22b8 (7)*serB*948913969pET22b8 (8)*radA*9489121,383pET22b8 (7)*yhdP*28477403,801pET22b8 (4)*yjjK*9489091,668pET22b8 (8)*slt*9489081,938pET22b8 (8)*yjiQ*948866561pET22b8 (6)*yjiR*9490891,413pET22b8 (8)*yjiS*948903165pET22b8 (8)*yjiT*9450561,503pET22b8 (6)*yjiV*28476692,937pET22b8 (7)*mcrC*9488801,047pET22b8 (8)*mcrB*9491221,380pET22b8 (6)*yjiW*7157066399pET22b8 (8)*hsdS*9488671,395pET22b8 (8)*hsdM*9488721,590pET22b8 (8)*hsdR*9488783,513pET22b8 (5)*mrr*948898915pET22b8 (8)*yjiA*948882957pET22b8 (8)*recB*9472863,543pET22b8 (5)*yjiY*9489142,151pET22b8 (8)*tsr*9488841,656pET22b8 (8)*yjiZ*9488791,362pET22b8 (7)*yjjM*7159433915pET22b8 (8)*yjjN*71594381,023pET22b8 (8)*mdoB*71594392,292pET22b8 (4)*yeeJ*9464987,077pET22b8 (6)*gasT*2520306pcDNA™ 3.18 (8)*mcm6*41752,466pcDNA™ 3.18 (6)*slc18a2*65711,545pcDNA™ 3.18 (7)Gene cluster 110 kbpET22b8 (5)Gene cluster 215 kbpET22b8 (6)Gene cluster 320 kbpET22b8 (4)^a^Number of colonies checked (number of positive colonies)

Application of MRF cloning in genes reconstitution {#Sec6}
--------------------------------------------------

In routine application of our cloning method, we created 46 constructs from *E. coli* genomic DNA and human cDNA (Clontech) with inserts of variable size (Table [2](#Tab2){ref-type="table"}). *E. coli* genes and gene clusters (Additional file [5](#MOESM5){ref-type="media"}: Table S2, Additional file [6](#MOESM6){ref-type="media"}: Table S3, and Additional file [4](#MOESM4){ref-type="media"}: Table S4) were cloned from the *E. coli* genome. The *E. coli* genes and gene clusters were subcloned into pET22b, with the gene under the control of a T7 promoter, and with a C-terminal His~6~-tag to facilitate protein purification (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). Human genes were subcloned into the expression vector pcDNA™ 3.1 (+) (Invitrogen) (Additional file [2](#MOESM2){ref-type="media"}: Figure S2). Under our test conditions, we achieved an average cloning efficiency of 86.9%. DNA sequencing revealed that all genes were correctly placed in the plasmid.

Discussion {#Sec7}
==========

In this study, we describe a new cloning method. The technique uses two rounds of PCR to obtain inserts and acceptors with compatible cohesive ends, which are then ligated. Using this method, we made 46 constructs with inserts of variable size. The average cloning efficiency was 86.9%, as determined by colony PCR and sequencing of the cloned genes. Because the method relies on PCR to generate cohesive 5' or 3' ends for DNA ligation, restriction sites are not needed, which facilitates cloning of the gene of interest. For convenience, we only used the vector pET22b for *E. coli* genes and pcDNA™ 3.1 (+) for human genes, but used inserts of variable size. Our results showed that cloning efficiency was not significantly affected by the different inserts, thus providing a glimpse of the wide choice in inserts that can be used as a template, which then can be used as an alternative method for multiple fragment assembly and library construction.

We noticed that cloning efficiency was not altered dramatically by fragment length. As shown in Table [2](#Tab2){ref-type="table"} and Additional file [7](#MOESM7){ref-type="media"}: Figure S3, this method was suitable for the cloning of large DNA sequences up to 20 kb in size. In contrast to traditional restriction enzyme cloning, the method described here provides a much more flexible approach to gene cloning. Therefore, it represents a cost-effective and simple solution for high-throughput cloning applications. Because this method relies on PCR amplification of the DNA sequences, the most crucial requirement is high-fidelity DNA polymerase. Fortunately, the high-fidelity polymerases recently developed for cloning, e.g., Phusion^®^ High-Fidelity DNA Polymerase and KOD Hot Start DNA Polymerase, have extremely low error rates. Therefore, it is no longer challenging to amplify large DNA fragments for use in our method.

Conclusions {#Sec8}
===========

We developed a novel cloning method that provides an alternative approach to DNA assembly. This method is independent of restriction sites and *Dpn*I treatment, and does not introduce undesired operational sequences at the junctions of functional modules. This new method simplifies complex cloning procedures in which long stretches of DNA can be inserted into circular plasmids in an unrestricted way, and the efficiency does not decrease for long inserts up to 20 kb. The simplicity of both primer design and the procedure itself makes the method suitable for high-throughput studies. The protein of interest is expressed without the addition of extra residues originating from the cloning procedure, making it an attractive alternative method for structural genomics.

Methods {#Sec9}
=======

Materials {#Sec10}
---------

Phusion® High-Fidelity DNA Polymerase, DNA marker, Taq DNA polymerase, and T4 DNA ligase were purchased from New England Biolabs, and cloning kits from Qiagen. pET22b, pcDNA™ 3.1 (+), and host strain *Escherichia coli* DH5α were obtained from Invitrogen. Human cDNAs were purchased from Clontech. Oligonucleotide primers were purchased from Invitrogen. PCR purification and gel extraction kits were purchased from Qiagen. Plasmids were isolated using a QIAprep Spin Miniprep Kit (Qiagen). All other chemicals used in the study were of molecular biology grade.

Touchdown PCR {#Sec11}
-------------

PCR reactions were performed to generate DNA fragments in a final volume of 50 μL using Phusion® High-Fidelity DNA Polymerase (New England Biolabs) and the primer pair as shown in Additional file [3](#MOESM3){ref-type="media"}: Table S1. After the initial denaturation step at 98 °C for 5 min, the PCR was conducted for 20 cycles with denaturation at 98 °C for 20 s; primer annealing from 60 °C to 50 °C with a step of -0.5 °C each cycle for 20 s; extension at 72 °C for 30 s/kb; and 10 cycles with an annealing temperature at 52 °C. When all cycles were completed, the samples were maintained at 72 °C for 10 min to finish all DNA synthesis.

Ligation {#Sec12}
--------

DNA ligation reactions were performed to fuse DNA fragments in a final volume of 20 μL using T4 DNA ligase (New England Biolabs) following the standard protocol from New England Biolabs. In brief, the longer and shorter DNA fragments were mixed at a molar ratio of 1:3--1:10. The reaction was incubated at room temperature for 2 h. After heat inactivation at 65 °C for 10 min, the reaction was chilled on ice. A 10 μL aliquot of the reaction was used to transform 50 μL of competent cells.

Colony PCR {#Sec13}
----------

For each transformation, eight colonies were selected randomly for colony PCR to verify insertion. The colony PCR included 5 units of Taq DNA polymerase (New England Biolabs) and 1× ThermoPol® Buffer (New England Biolabs) in the presence of 200 μM dNTP, 1 mmol each of a primer from the vector and a primer from the insert gene, and a small amount of cells picked from the colony, all in a final volume of 20 μL. The colony PCR conditions were as follows: 95 °C for 2 min; 25 cycles of 95 °C for 30 s, 50 °C for 30 s, and 68 °C for 1 min/kb; and a final extension at 68 °C for 10 min. Insert-positive constructs were confirmed by DNA sequencing.

Isolation and purification of total genomic DNA from *E. coli* {#Sec14}
--------------------------------------------------------------

Mid-log phase *E. coli* DH5α cells were collected by centrifugation at 4 °C for 10 min. The pellet was resuspended in 190 μL of TE supplemented with 10 μL of 10% SDS and 1 μL of 20 mg/mL protease K, and then incubated at 37 °C for 1 h. After 1 h, 30 μL of 5 M NaCl and 30 μL of CTAB/NaCl were added to the solution, and the sample was incubated at 65 °C for 20 min. After incubation, 300 μL of phenol/chloroform/isoamyl alcohol (25:24:1, v/v) was added, and the sample was immediately mixed and centrifuged at 5000 rpm in a table-top microcentrifuge for 10 min. To the upper (aqueous) phase 300 μL of chloroform/isoamyl alcohol (24:1) was added, which was mixed and centrifuged at 5000 rpm. To the resultant aqueous phase 300 μL of isoamyl alcohol was added; after mixing, the sample was incubated at room temperature for 10 min to precipitate DNA. To pellet DNA, the sample was centrifuged at 5000 rpm for 10 min. The pellet was resuspended in 500 μL of 70% ethanol and centrifuged at 5000 rpm for 10 min. The supernatant was discarded, and the pellet was dried and dissolved in 20 μL of TE buffer.

Plasmid transformation and isolation {#Sec15}
------------------------------------

The competent DH5α cells were prepared by calcium chloride method \[[@CR24]\]. The ligation product (10 μL) was added directly to 50 μL of competent DH5α cells, incubated for 15 min on ice, heat-shocked at 42 °C for 1 min, and then transferred on ice for 5 min. After adding 500 μL of LB, the cells were incubated in a shaker at 37 °C for 60 min. After incubation, cells were pelleted and resuspended in 100 μL of LB, which was then spread on LB plates containing ampicillin (100 μg/mL). After overnight incubation at 37 °C, eight colonies from each transformation were randomly picked and checked by colony PCR. Plasmids were isolated using the Spin Miniprep kit (Qiagen).

Additional files {#Sec16}
================

Additional file 1: Figure S1.Map of pET22b cloning region. The blue line shows the 5' overhang sequence, and the green line shows the 3\' overhang sequence. The red arrows, A and B, show the reconstituted sites. (PDF 216 kb) Additional file 2: Figure S2.Map of pcDNA3.1 (+) cloning region. The blue line shows the 5' overhang sequence, and the green line shows the 3' overhang sequence. The red arrows, A and B, show the reconstituted sites. (PDF 202 kb) Additional file 3: Table S1.Primers used in this study. (DOCX 33 kb) Additional file 4: Table S4.20 kb DNA fragments from *E.coli* genome. (DOCX 17 kb) Additional file 5: Table S2.10 kb DNA fragments from *E.coli* genome. (DOCX 13 kb) Additional file 6: Table S3.15 kb DNA fragments from *E.coli* genome. (DOCX 13 kb) Additional file 7: Figure S3.Cloning efficiency of selected genes. Data obtained from Table [2](#Tab2){ref-type="table"}. (PDF 67 kb)
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dNTP
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:   Restriction-free cloning
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